Status:
TERMINATED
Brain Perfusion Assessment in the Acute Phase of Migraine Aura
Lead Sponsor:
Nantes University Hospital
Conditions:
Emergencies
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the study is to determine the proportion of patients with change in brain perfusion during the acute phase of migraine attack with aura.
Detailed Description
Migraine is a benign and frequent disorder. Migraine aura consists in reversible focal neurological symptoms developing gradually during attack. Its diagnosis relies mainly on patient's history, clini...
Eligibility Criteria
Inclusion
- Age between greater than or equal to 18
- Able to undergo MRI during migraine aura
Exclusion
- Pregnant females
- Contraindications towards MRI scanning
- History of epilepsy, psychiatric disease, or any other neurologic disease (brain tumors, stroke..).
- Presence of abnormalities on the MRI that could explain the neurological deficit.
- Adults under guardianship or trusteeship
Key Trial Info
Start Date :
March 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 22 2021
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT03821584
Start Date
March 1 2019
End Date
July 22 2021
Last Update
September 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Nantes
Nantes, France, 44000